
Our medicines
We are a global biopharmaceutical company focused on helping to address the unmet medical needs of patients with serious diseases. In 2022, we invested $9.5 billion in R&D, which included the discovery and development of new medicines.
Patients & caregivers
Our medicines
Report side effects or product quality complaints
1-800-721-5072
(toll free U.S. only)
Report side effects or product quality complaints about legacy celgene products (ABRAXANE ® , IDHIFA ® , INREBIC ® , ISTODAX ® , POMALYST ® , REBLOZYL ® , REVLIMID ® , THALOMID ® , VIDAZA ® )
Learn more >
Below is a list of our company's marketed products. Any linked documents and websites are intended only for U.S. residents 18 years or older, as the availability of medicines and the indications for which they are approved can vary with country and region.
ABECMA ®
(idecabtagene vicleucel)
U.S. full prescribing information including
Boxed WARNINGS
Medication guide
Product website
ABRAXANE ®
(paclitaxel protein-bound particles for injectable suspension) (albumin-bound)
U.S. full prescribing information including
Boxed WARNINGS
Patient information
Patent information
Product website
Pricing information
AUGTYRO ™  (repotrectinib)
U.S. full prescribing information
Patient information
Product website
AZACTAM ®
(aztreonam for injection, USP)
U.S. full prescribing information
BREYANZI ®  (lisocabtagene maraleucel)
U.S. full prescribing Information including
Boxed WARNINGS
Medication guide
BARACLUDE ®
(entecavir)
U.S. full prescribing information including
Boxed WARNINGS
Patient information
CAMZYOS ®
(mavacamten)
U.S. full prescribing information including
Boxed WARNING
Medication guide
ELIQUIS ®
(apixaban)
U.S. full prescribing information including
Boxed WARNINGS
Medication guide
Product website
Pricing nformation
Eliquis® (apixaban) Recall lot HN0063 - FAQs for patients
EMPLICITI ®
(elotuzumab)
U.S. full prescribing information
Patient information
Product website
Pricing information
EVOTAZ ®
(atazanavir and cobicistat)
U.S. full prescribing information
Patient information
Product website
IDHIFA ®
(enasidenib)
U.S. full prescribing information including
Boxed WARNINGS
Patient information
Product website
Pricing information
INREBIC ®
(fedratinib)
U.S. full prescribing information including
Boxed WARNINGS
Patient information
Product website
Pricing information
ISTODAX ®
(romidepsin)
U.S. full prescribing information
Patient information
KENALOG ® -10 (triamcinolone acetonide)
U.S. full prescribing information
KENALOG ®
-40 (triamcinolone acetonide) and
KENALOG ®
-80 (triamcinolone acetonide)
U.S. full prescribing information
KRAZATI ®  (adagrasib)
U.S. full prescribing information
Patient information
Product website
NULOJIX ®
(belatacept)
U.S. full prescribing information including  Boxed WARNINGS
Medication guide
Product website
Pricing information
ONUREG ®
(azacitidine tablets)
U.S. full prescribing information
Patient information
Product website
Pricing information
OPDIVO ®
(nivolumab)
U.S. full prescribing information for OPDIVO
Medication guide for OPDIVO
U.S. full prescribing information for YERVOY (ipilimumab)
Medication guide for YERVOY
Product website
Pricing information
OPDUALAG ™  (nivolumab and relatlimab-rmbw)
U.S. full prescribing information
Medication guide
ORENCIA ®
(abatacept)
U.S. full prescribing information
Patient information
Instructions for use
Product website
Pricing information for intravenous use
Pricing information for self-injection use
POMALYST ®
(pomalidomide)
U.S. full prescribing information including
Boxed WARNINGS
Patient information
Product website
REBLOZYL ®
(luspatercept-aamt)
U.S. full prescribing information
Patient information
Product website
REVLIMID ®
(lenalidomide)
U.S. full prescribing information including
Boxed WARNINGS
Patient information
Product website
REYATAZ ®
(atazanavir)
U.S. full prescribing information
Patient information
Instructions for use
Product website
SOTYKTU ™  (deucravacitinib)
U.S. full prescribing information
Medication guide
SPRYCEL ®
(dasatinib)
U.S. full prescribing information
Patient information
Product website
Pricing information
THALOMID ®
(thalidomide)
U.S. full prescribing information
Patient information
VIDAZA ®
(azacitidine)
U.S. full prescribing information
YERVOY ®
(ipilimumab)
U.S. full prescribing information
Medication guide
Product website
ZEPOSIA ®  (ozanimod)
U.S. full prescribing information
Medication guide
Product website
Legacy brands
DROXIA ®
(hydroxyurea)
U.S. full prescribing information including
Boxed WARNING
Medication guide
HYDREA ®
(hydroxyurea)
U.S. full prescribing information
Prescribing information
Please click below to see the full U.S. Prescribing Information, including  Boxed WARNING  and Medication Guide/Patient Information   for:
ABECMA ®
Medication guide
Prescribing information
ABRAXANE ®
Patient information
Prescribing information
BREYANZI ®
Medication guide
Prescribing information
BARACLUDE ®
Patient information
Prescribing information
CAMZYOS ®
Prescribing information
DROXIA ®
Prescribing information
ELIQUIS ®
Medication guide
Prescribing information
IDHIFA ®
Patient information
Prescribing information
INREBIC ®
Patient information
Prescribing information
KRAZATI ®
Patient information
Prescribing information
POMALYST ®
Patient information
Prescribing information
REVLIMID ®
Patient information
Prescribing information
THALOMID ®
Patient information
Prescribing information
NULOJIX ®
Medication guide
Prescribing information
YERVOY ®
Medication guide
Prescribing information
